Ciprofloxacin-induced renal insufficiency in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 2, Issue 3, 2003, Pages 152-154

  Moffett, Brady S ^a,b   Rosenstein, Beryl J ^a   Mogayzel Jr , Peter J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Ciprofloxacin; Cystic fibrosis; Nephrotoxicity; Renal insufficiency

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DORNASE ALFA; ETHAMBUTOL; FLUTICASONE PROPIONATE PLUS SALMETEROL; ISONIAZID; NORTRIPTYLINE; OMEPRAZOLE; PANCREAS ENZYME; PYRIDOXINE; RIFABUTIN; SALBUTAMOL; THEOPHYLLINE; TOBRAMYCIN; VITAMIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CASE REPORT; CYSTIC FIBROSIS; DRUG INDUCED DISEASE; ECHOGRAPHY; ELDERLY CARE; FEMALE; HUMAN; INCIDENCE; LABORATORY TEST; LUNG INFECTION; MYCOBACTERIUM INTRACELLULARE AVIUM; NAUSEA; NEPHROTOXICITY; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; SYMPTOMATOLOGY; URINALYSIS; VOMITING;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; BLOOD UREA NITROGEN; CIPROFLOXACIN; CREATININE; CYSTIC FIBROSIS; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE;

EID: 0041859506     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(03)00059-6     Document Type: Article

References (15)

1. Lomaestro B.M. Fluoroquinolone-induced renal failure Drug Saf 22 2000 479-485
2. Richard D.A. Nousia-Arvanitakis S. Sollich V. Hampel B.J. Sommerauer B. Schaad U.B. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic fibrosis study group Pediatr Infect Dis J 16 1997 572-578
3. Patterson D.R. Quinolone toxicity: methods of assessment Am J Med 91 1991 35S-37S
4. Bald M. Ratjen F. Nikolaizik W. Wingen A.M. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis Pediatr Infect Dis J 20 2001 320-321
5. Gerritsen W.R. Peters A. Henny F.C. Brouwers J.R. Ciprofloxacin-induced nephrotoxicity Nephrol Dial Transplant 2 1987 382-383
6. Hampel B. Hullmann R. Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report Pediatr Infect Dis J 16 1997 127-129 Discussion 160-122
7. Ball P. Ciprofloxacin: an overview of adverse experiences J Antimicrob Chemother 18 Suppl. D 1986 187-193
8. Alghasham A.A. Nahata M.C. Clinical use of fluoroquinolones in children Ann Pharmacother 34 2000 347-359 Quiz 413-344
9. Lumbiganon P. Pengsaa K. Sookpranee T. Ciprofloxacin in neonates and its possible adverse effect on the teeth Pediatr Infect Dis J 10 1991 619-620
10. Bailey J.R. Trott S.A. Philbrick J.T. Ciprofloxacin-induced acute interstitial nephritis Am J Nephrol 12 1992 271-273
11. Schaefer H.G. Stass H. Wedgwood J. Hampel B. Fischer C. Kuhlmann J. Schaad U.B. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients Antimicrob Agents Chemother 40 1996 29-34
12. Jick S. Ciprofloxacin safety in a pediatric population Pediatr Infect Dis J 16 1997 130 133 Discussion 133-134, 160-132
13. Sakarcan A. Marcille R. Stallworth J. Antibiotic-induced recurring interstitial nephritis Pediatr Nephrol 17 2002 50-51
14. Dharnidharka V.R. Nadeau K. Cannon C.L. Harris H.W. Rosen S. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes Am J Kidney Dis 31 1998 710-712
15. Simpson J. Watson A.R. Mellersh A. Nelson C.S. Dodd K. Typhoid fever, ciprofloxacin and renal failure Arch Dis Child 66 1991 1083-1084